OnSite Waste Technologies Secures $3.5M Seed Funding to Advance Compact Medical Waste Processor

VCBeat (WeChat ID: vcbeat) has learned that medical waste disposal company OnSite Waste Technologies recently completed a $3.5 million seed funding round. The round was led by Mark IV Capital and Cove Fund. The funds will be used to expand the company’s team and promote its novel medical waste treatment technology across the United States.

OnSite Waste Technologies was founded in California, USA, in 2013 and is a leading company in the field of medical waste treatment technology. The company is committed to treating medical waste in a simple, intelligent, and safe manner to save time, reduce costs, and improve resource utilization.

For a long time, medical waste has required transportation to specialized facilities for disposal. Traditional treatment methods not only incur high costs but also fail to ensure safety during transit. To address this, OnSite Waste Technologies has developed a medical waste processor called the TE-5000. This desktop-sized unit can be placed in an office and converts regulated medical waste into sterile trash.

Industry experts consider the TE-5000 to be the most comprehensive waste disposal solution currently available. Reportedly, this processor has passed audits by 75 different regulatory agencies and is approved for use in healthcare facilities across all 50 U.S. states. For a fixed monthly fee, healthcare professionals can use the TE-5000 in their offices to sterilize hazardous medical waste. The treatment process takes approximately 2.5 hours, after which the treated medical waste can be disposed of directly in regular trash bins. The processor is capable of handling 3 to 4 gallons of medical waste per day.

The CEO of OnSite Waste Technologies stated, “For decades, there has been little innovation in medical waste disposal technology, and the medical waste management market is in urgent need of safe and convenient medical waste disposal solutions.” According to a report by Transparency Market Research, the global medical waste management market exceeded $10 billion in 2016 and is projected to surpass $22.3 billion by 2025.

It is understood that medical waste refers to waste with direct or indirect infectious and toxic properties generated by healthcare institutions during medical, preventive, and healthcare activities. In the United States, medical waste is primarily categorized into sharps (such as hypodermic needles and scalpels) and Red Bag waste (containers holding blood or potentially infectious materials).

Mark IV Capital, established in 1974, is a venture capital firm headquartered in California, United States.

Cove Fund, established in 2018, is an investment firm headquartered in California, USA. The firm is dedicated to providing financial support to startups in Southern California.

(Compiled by Jiao Yanli)